In April 2020, when the COVID-19 testing infrastructure in Philadelphia was leaving Black neighborhoods uncovered, Dr. Ala Stanford founded a mobile, barrier-free testing operation. The operation she founded, the Black Doctors COVID-19 Consortium, says it has since tested and vaccinated more than 100,000 patients in Southeastern Pennsylvania.
Five years later, Stanford has done a tour through the federal government (HHS Region 3 Director from April 2022 to May 2023) and landed at the University of Pennsylvania, where she directs community outreach for the Penn Institute for RNA Innovation. The throughline across the arc is the same: when the medical system does not show up for Black communities, she builds the infrastructure that does.
Who she is
Stanford is a board-certified pediatric surgeon. She trained at Pennsylvania State University College of Medicine, completed general surgery training in Brooklyn and Pittsburgh and a pediatric surgery fellowship at Cincinnati Children's Hospital Medical Center, and ran R.E.A.L. Concierge Medicine, her own practice, before COVID. The pivot from private surgical practice to public-health organizer was not a planned career move. It was the response to what she could see was failing in real time, on her own block.
The honors stack since 2020 reads like a list of late-career awards on someone who is mid-career: the Philadelphia Award (2021), CNN Heroes Top 10 (2021), and USA Today's Women of the Year (2022). The point of naming them is not the awards themselves. It is that the federal-government, mainstream-media, and academic-medicine systems all looked at the same career arc and recognized it for the same reason. The work was real and it worked.
What BDCC actually did
The Black Doctors COVID-19 Consortium ran free testing and later free vaccination clinics out of Black churches, community centers, and parking lots in Philadelphia and the broader Delaware Valley. By its own count, the consortium has tested and vaccinated more than 100,000 patients in Southeastern Pennsylvania. The model the BDCC built paired trusted Black clinicians and community spaces with testing and vaccination that is barrier free.
The reason BDCC mattered, statistically, is the gap it filled. In 2020, the age-adjusted COVID-19 death rate for Black Americans was 151.1 per 100,000, against 72.5 for white Americans (CDC provisional data). Philadelphia's Black neighborhoods were on the wrong side of that distribution; BDCC moved testing access into them physically, before the city's official infrastructure caught up.
It is one of the cleanest case studies of what a Black-led, community-trusted health response looks like when the disparity numbers are running in real time.
What she did at HHS
From April 2022 to May 2023, Stanford served as the Regional Director for HHS Region 3 (Pennsylvania, Delaware, Maryland, Virginia, West Virginia, and DC). HHS describes its regional directors as the Secretary's representatives who keep the department in close contact with state, local, and tribal partners. It is a senior federal post, filled by presidential appointment.
Her HHS post ended in May 2023, according to her CV. The federal chapter is less visible than the BDCC-era pandemic response.
Community health centers test and treat COVID on a sliding scale, often for less than a telehealth visit's own fee. Our directory of free and charitable clinics lists centers by state. A same-day telehealth visit is self-pay and is not billed to Medicaid, so check the clinic route first. If you want a telehealth visit sooner:
Sesame Care
A same-day online visit with a licensed clinician for COVID symptoms, testing guidance, and treatment options. Prices are shown before you book; visits start at $34 and vary by clinician and location (checked August 2026).
See a clinician todaySponsored
What she is doing now
Stanford is currently a Professor of Practice in the Department of Biology at the University of Pennsylvania and directs Community Outreach for the Penn Institute for RNA Innovation. The Institute focuses on RNA-based therapeutics (the same biological platform that mRNA vaccines are built on) and her remit there is the community-engagement layer: making sure the next generation of RNA medicines actually reaches Black patients, who were under-represented in mRNA vaccine trial cohorts and remain under-represented in most US clinical trials.
That is the through-line worth tracking. BDCC was about getting the existing technology to Black patients during a pandemic. The Penn Institute work is about making sure the next generation of biomedical innovation does not start from a Black-under-representation baseline.
How to follow her work
BDCC continues to operate as an initiative of It Takes Philly, Inc., a 501(c)(3) nonprofit, at blackdoctorsconsortium.com; the site lists current testing and vaccination services plus community-health partnerships in the Delaware Valley.
Her University of Pennsylvania faculty page lists her X handle as @alastanford. Her Wikipedia page collects the verifiable awards, affiliations, and historical record.
What you can take from this
Three concrete moves.
First, if you live in the Delaware Valley, BDCC is still operating; check the site for current testing, vaccination, and community-health services.
Second, the structural lesson Stanford has been making on the record for five years is that Black-community health infrastructure works when it is built by Black clinicians, in Black community spaces, free at the point of contact. If you are a clinician or organizer thinking about the next chapter of community-health response (climate-related health, the next pandemic, structural-disease outreach), her model is the working template.
Third, RNA-platform medicine is the next decade of clinical innovation. Black under-representation in trial cohorts is the standing equity problem the Penn Institute is trying to solve. Our piece on finding a Black doctor covers the workforce numbers; the Penn Institute work is the trial-recruitment-side companion. Both are needed.
Citations
Black Doctors COVID-19 Consortium. blackdoctorsconsortium.com.
Penn Institute for RNA Innovation. med.upenn.edu/rna.
U.S. Department of Health and Human Services Region 3. Stanford served as Regional Director, April 2022 to May 2023 (per her curriculum vitae, July 2024).
Stanford A. Curriculum vitae, July 2024. University of Pennsylvania Department of Biology faculty page.